The Patent Finder

Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof (2020)

Halozyme Hypercon, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2019/033875, filed May 24, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,263,253Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof
In force
 · High confidence
Halozyme Hypercon, Inc.In force
High confidence
US 12,433,849Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof
In force
 · High confidence
Halozyme Hypercon, Inc.In force
High confidence
US 12,115,262Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof
In force
 · High confidence
Halozyme Hypercon, Inc.In force
High confidence
Application 19/321,930Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Halozyme Hypercon, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited